The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study
- PMID: 21094992
- PMCID: PMC3014381
- DOI: 10.1016/j.urology.2010.07.516
The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study
Abstract
Objective: Men with type 2 diabetes have lower concomitant prostate-specific antigen (PSA) levels; however, the influence of metabolic conditions on PSA changes over time remains unknown. Therefore, the goal of this study was to assess associations between type 2 diabetes and hypertension and changes in serum PSA levels.
Methods: In 1990, a randomly selected cohort of Caucasian men, ages 40-79, from Olmsted County, MN completed questionnaires ascertaining demographic characteristics, current medical conditions and medications biennially, with 633 men undergoing blood draws. Men with a physician diagnosis of diabetes or hypertension at baseline, or who reported using medications to treat these conditions prior to baseline were considered exposed. Men with at least two serum PSA measurements (n = 569) were included in this analysis. Linear mixed models were used to estimate the annual percent change in serum PSA levels associated with diabetes and hypertension, adjusting for baseline age.
Results: The overall mean change in serum PSA levels was 3.6% per year and increased with age (P = .009). Men with diabetes experienced less annual change in serum PSA levels (1.1%) than did non-diabetic men (3.7%), adjusting for age (P = .02). Age-adjusted change in serum PSA levels differed little by hypertension status (3.7% vs. 3.6%; P = .49).
Conclusions: Our results suggest that Caucasian men with type 2 diabetes experience smaller increases in serum PSA levels as they age compared to men without diabetes. Additional research is needed to elucidate whether this difference results in a relatively lower incidence of prostate cancer or less cancer detection among diabetic men.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
Comment in
-
Editorial comment.Urology. 2011 Jan;77(1):141-2. doi: 10.1016/j.urology.2010.08.018. Urology. 2011. PMID: 21195834 No abstract available.
Similar articles
-
The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):501-8. doi: 10.1158/1055-9965.EPI-10-1006. Epub 2011 Jan 17. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21242331 Free PMC article.
-
Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.Urology. 2014 Jan;83(1):88-93. doi: 10.1016/j.urology.2013.08.025. Epub 2013 Oct 16. Urology. 2014. PMID: 24139354 Free PMC article.
-
Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.Mayo Clin Proc. 2012 Jan;87(1):34-40. doi: 10.1016/j.mayocp.2011.09.002. Mayo Clin Proc. 2012. PMID: 22212966 Free PMC article.
-
Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.Urology. 2001 Jan;57(1):91-6. doi: 10.1016/s0090-4295(00)00873-6. Urology. 2001. PMID: 11164150 Review.
-
Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis.Clin Chem Lab Med. 2020 Jul 20;59(1):11-26. doi: 10.1515/cclm-2020-0145. Clin Chem Lab Med. 2020. PMID: 32681769
Cited by
-
Association between body mass index and hemoglobin A1c with serum prostate-specific antigen level: A retrospective cohort study.Saudi Med J. 2023 Sep;44(9):870-874. doi: 10.15537/smj.2023.44.9.20230384. Saudi Med J. 2023. PMID: 37717968 Free PMC article.
-
Association of obesity and diabetes with serum prostate-specific antigen levels in Japanese males.Nagoya J Med Sci. 2012 Aug;74(3-4):285-92. Nagoya J Med Sci. 2012. PMID: 23092101 Free PMC article.
-
New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication.Int J Cell Biol. 2013;2013:834684. doi: 10.1155/2013/834684. Epub 2013 Mar 19. Int J Cell Biol. 2013. PMID: 23573093 Free PMC article.
-
Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes.J Urol. 2015 Mar;193(3):786-93. doi: 10.1016/j.juro.2014.08.115. Epub 2014 Sep 11. J Urol. 2015. PMID: 25218922 Free PMC article. Clinical Trial.
-
Outcomes of prostate cancer screening among men using antidiabetic medication.Sci Rep. 2021 Apr 1;11(1):7363. doi: 10.1038/s41598-021-86534-2. Sci Rep. 2021. PMID: 33795720 Free PMC article.
References
-
- National Cancer I Estimated new cases and deaths of prostate cancer. 2007
-
- Society AC Cancer Facts & Figures 2010. 2010
-
- Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320–8. - PubMed
-
- Centers for Disease C and Prevention Health, United States, 2007. 2007
-
- Division of N and Physical A Overweight and Obesity. 2007
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous